David Ben Naim
2016
In 2016, David Ben Naim earned a total compensation of $6K as Chief Financial Officer Executive Officers of the Company in 2016 Through Merger at StemCells.
Compensation breakdown
| Salary | $6,000 |
|---|---|
| Total | $6,000 |
Naim received $6K in salary, accounting for 100% of the total pay in 2016.
Rankings
In 2016, David Ben Naim's compensation ranked 14,043rd out of 14,075 executives tracked by ExecPay.
| Classification | Ranking | Percentile |
|---|---|---|
All | 14,043 out of 14,075 | 0th |
Division Manufacturing | 5,476 out of 5,489 | 0th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 824 out of 827 | 0th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 507 out of 510 | 1st |
Industry Surgical and Medical Instruments and Apparatus | 310 out of 313 | 1st |
Source: SEC filing on August 11, 2017.
Naim's colleagues
We found seven more compensation records of executives who worked with David Ben Naim at StemCells in 2016.
2016
Martin McGlynn
StemCells
Chief Executive Officer
2016
Kenneth Stratton
StemCells
General Counsel
2016
George Koshy
StemCells
Chief Accounting Officer
2016
Gregory Schiffman
StemCells
Chief Financial Officer
2016
Ian Massey
StemCells
Chief Executive Officer
2016
Harel Gadot
StemCells
Chief Executive Officer
2016
Hezi Himelfarb
StemCells